Page 113 - 202013

BJU Int，1999，84（3）：276-279. [15] ABDELAAL AM，AL-ADL AM，ABDELBAKI SA，et al.
[ 4 ] DAMIANO R，AUTORINO R，DE SIO M，et al. Does the Effcacy and safety of tamsulosin oral-controlled absorp-
size of ureteral stent impact urinary symptoms and quality tion system，solifenacin，and combined therapy for the
of life：a prospective randomized study[J]. Eur Urol， management of ureteric stent-related symptoms[J]. Arab J
2005，48（4）：673-678. Urol，2016，14（2）：115-122.
[ 5 ] BETSCHART P，ZUMSTEIN V，PILLER A，et al. Preven- [16] KOPROWSKI C，KIM C，MODI PK，et al. Ureteral stent-
tion and treatment of symptoms associated with indwell- associated pain：a review[J]. J Endourol，2016，30（7）：
ing ureteral stents：a systematic review[J]. Int J Urol， 744-753.
2017，24（4），250-259. [17] DAVENPORT K，TIMONEY AG，KEELEY FX. A com-
[ 6 ] JOSHI HB，NEWNS N，STAINTHORPE A，et al. Ureteral parative in vitro study to determine the beneficial effect of
stentsymptom questionnaire：development and validation calcium-channel and alpha（1）-adrenoceptor antagonism
of a multi-dimensional quality of life measure[J]. J Urol， on human ureteric activity[J]. BJU Int，2006，98（3）：
2003，169（3）：1060-1064. 651-655.
[ 7 ] WANG CJ，HUANG SW，CHANG CH. Effects of specif- [18] DAVENPORT K，TIMONEY AG，KEELEY FX JR. Ef-
ic alpha-1A/1D blocker on lower urinary tract symptoms fect of smooth muscle relaxant drugs on proximal human
due to double-J stent：a prospectively randomized study[J]. ureteric activity in vivo：a pilot study[J]. Urol Res，2007，
Urol Res，2009，37（3）：147-152. 35（4）：207-213.
[ 8 ] 张志强，于德新，谢栋栋，等.托特罗定联合坦索罗辛治疗 [19] DELIVELIOTIS C，CHRISOFOS M，GOUGOUSIS E，
双 J 管置入后相关症状的临床观察[J].中华泌尿外科杂 et al. Is there a role for alpha1-blockers in treating dou-
志，2012，33（9）：692-695. ble-J stent-related symptoms?[J]. Urology，2006，67（1）：
[ 9 ] DELLIS AE，KEELEY FX JR，MANOLAS V，et al. Role 35-39.
of a-blockers in the treatment of stent-related symptoms：a [20] EL-NAHAS AR，THARWAT M，ELSAADANY M，et al.
prospective randomized control study[J]. Urology，2014， A randomized controlled trial comparing alpha blocker
83（1）：56-61. （tamsulosin） and anticholinergic （solifenacin） in treat-
[10] SINGH I，TRIPATHY S，AGRAWAL V. Efficacy of tamsu- ment of ureteral stent-related symptoms[J]. World J Urol，
losin hydrochloride in relieving“double-J ureteral stent- 2016，34（7）：963-968.
related morbidity”：a randomized placebo controlled clini- [21] ZHOU L，CAI X，LI H，et al. Effects of α-blockers，anti-
cal study[J]. Int Urol Nephrol，2014，46（12）：2279-2283. muscarinic，or combination therapy in relieving ureteral
[11] PARK J，YOO C，HAN DH，et al. A critical assessment of stentrelated symptoms：a meta-analysis[J]. J Endourol，
the effects of tamsulosin and solifenacin as monotherapies 2015，29（6）：650-656.
and as a combination therapy for the treatment of ureteral [22] HE F，MAN L，LI G，et al. Efficacy of α-blocker in im-
stent related symptoms：a 2×2 factorial randomized trial proving ureteral stent-related symptoms：a meta-analysis
[J]. World J Urol，2015，33（11）：1833-1840. of both direct and indirect comparison[J]. Drug Des Devel
[12] AGGARWAL SP，PRIYADARSHI S，TOMAR V，et al. A Ther，2016. DOI：10.2147/DDDT.S103195.
randomized controlled trial to compare the safety and effi- [23] YAN H，WANG Y，SUN R，et al. The efficacy of antimus-
cacy of tadalafil and tamsulosin in relieving double J stent carinic alone or in combination with alpha-blockers for
related symptoms[J]. Adv Urol，2015.DOI：10.1155/2015/ the treatment of ureteral stent-related symptoms：a system-
592175. atic review and meta-analysis[J]. Urol Int，2016，99（1）：
[13] 李守国，李九智，王晨宇，等.坦索罗辛单用与联合托特罗 6-13.
定治疗输尿管支架置入术后不适的疗效比较[J].中国新 [24] CHEN YB，GAO L，JIANG Q，et al. Tamsulosin mono-
药与临床杂志，2016，35（8）：567-570. therapy is effective in reducing ureteral stent-related symp-
[14] DELLIS AE，PAPATSORIS A，KEELEY FX，et al. Tamsu- toms：a meta-analysis of randomized controlled studies
losin，solifenacin，and their combination for the treatment [J]. Cur Med Sci，2019，39（5）：707-718.
of stent-related symptoms：a randomized controlled study （收稿日期：2020-02-07 修回日期：2020-04-14）
[J]. J Endourol，2017，31（1）：100-109. （编辑：刘明伟）

中国药房 2020年第31卷第13期 China Pharmacy 2020 Vol. 31 No. 13 ·1639 ·